Trial Details
RECRUITINGBasic Information
| Clinical ID | c380 |
|---|---|
| Identifier | NCT06691061 |
| Trial Title | The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (Disorder) |
| Interventions | DRUG: Vedolizumab|DRUG: Ustekinumab - Standard Dosage|DRUG: JAK Inhibitor |
Participant Information
| Sponsor | Humanitas Clinical and Research Center |
|---|---|
| City | Italy |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2023-08-01 |
|---|---|
| Primary Completion Date | 2024-12-31 |
| Completion Date | 2024-12-31 |